Patents by Inventor Margaret A. Baker

Margaret A. Baker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for inducing an immune response to pulmonary infections
    Patent number: 10953081
    Abstract: The invention provides methods and compositions for preventing or ameliorating pulmonary infections with Pseudomonas aeruginosa.
    Type: Grant
    Filed: October 2, 2019
    Date of Patent: March 23, 2021
    Assignee: The Administrators of the Tulance Educational Fund
    Inventors: Lisa Ann Morici, Sarah Margaret Baker
  • METHODS AND COMPOSITIONS FOR PREVENTING OR AMELIORATING PSEUDOMONAS AERUGINOSA PULMONARY INFECTIONS
    Publication number: 20200138934
    Abstract: The invention provides methods and compositions for preventing or ameliorating pulmonary infections with Pseudomonas aeruginosa.
    Type: Application
    Filed: October 2, 2019
    Publication date: May 7, 2020
    Applicant: The Administrators of the Tulane Educational Fund
    Inventors: Lisa Ann MORICI, Sarah Margaret BAKER
  • Process for preparing shelf stable pasta
    Patent number: 5958488
    Abstract: A process of preparing a shelf stable pasta having a moisture content of from about 15 to about 35% which comprises preparing a fresh pasta, steaming the fresh pasta, partially drying to a moisture content of from about 15 to about 35%, coating the partially dried pasta with a solid humectant in particulate form before or after placing in a package, and packaging the pasta in a container optionally under modified atmospheric conditions.
    Type: Grant
    Filed: April 25, 1997
    Date of Patent: September 28, 1999
    Assignee: Nestec S.A.
    Inventors: Janice Margaret Baker, Gene Frank Clyde
  • Treatment of gynecological malignancies with biologically active peptides
    Patent number: 5635479
    Abstract: A process for treating a gynecological malignancy in a host which comprises administering to the host at least one biologically active amphiphilic peptide or protein. The peptide or protein may be administered intralesionally, intravenously, or intraperitoneally, whereby the peptide or protein may inhibit, prevent, or destroy the growth of the gynecological malignancy, such as an ovarian cancer, uterine cancer, or cervical cancer.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: June 3, 1997
    Assignee: Magainin Pharmaceuticals Inc.
    Inventors: Leonard S. Jacob, W. Lee Maloy, Margaret A. Baker
  • Method for reducing unwanted cellular adhesions
    Patent number: 5480901
    Abstract: A conjugate comprising a drug which has an inhibitory effect on cellular adhesion and a lipophilic cell binding agent, when applied to a compromised site, e.g., due to surgical intervention, injury, chemotherapy, disease or inflammation, is effective in reducing unwanted adhesion formation.
    Type: Grant
    Filed: October 7, 1994
    Date of Patent: January 2, 1996
    Assignee: Zynaxis, Inc.
    Inventors: Margaret A. Baker, Betsy M. Ohlsson-Wilhelm